A federal court denied Johnson & Johnson's motion to implement a 340B drug rebate model, siding with HHS and hospitals who argued it violated program intent.

Mesoblast plans to file a BLA for Revascor by year-end after aligning with FDA on trial design, potency assays, and ...

Unisound AI Technology Co. Ltd. (9678.HK) made its Hong Kong trading debut on Monday, offering investors a new artificial ...

IBM expands DevOps capabilities with DBmaestro OEM deal to streamline database automation and boost software delivery.

The price movement demonstrated how commodity traders understand the world better than most, as oil dropped as much as 12.5% on Monday, reaching around $68 per barrel, before closing the week at ...

CNBC Host, Jim Cramer is optimistic about Amazon.com Inc. (NASDAQ: AMZN), despite the ongoing tariff pressures. His ...

Dan Ives has reiterated his bullish stance on Tesla, positioning it as one of the premier investments in the field of ...

The stablecoin space has matured rapidly. The next chapter of the evolution of stablecoins isn't about humans.

The Centers for Medicare & Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pays home health agencies (HHAs) in calendar year (CY) 2026. These updates are ...

Jim Cramer recommends buying Rio Tinto due to its high yield. TG Therapeutics is also a buy, with strong first-quarter sales ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Massimo MAMO stock fell 18.9% to $1.8 during Tuesday's pre-market session. The market value of their outstanding shares is at $92.2 million. Kaixin Hldgs KXIN shares decli ...